JASON DEAL: Open Payments
NPI 1629749619 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,233 in 37 payments from 10 companies in 2025. Trend: 2023 $224 · 2024 $401 · 2025 $2,233
Food & beverage: $1,336Travel & lodging: $897
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 19 | $1,619 |
| Amgen Inc. | 8 | $214 |
| Impulse Dynamics (USA) Inc. | 1 | $168 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Edwards Lifesciences Corporation | 1 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Analog Devices Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $15 |
Products named: Barostim Neo System, Optimizer, REPATHA, LEQVIO, PASCAL, LIVTENCITY, Sensinel CPM Wearable, WAINUA.
Industry payments across TX — which companies pay providers there.
